The presence and/or absence of a KRAS nonreference allele (i.e., potential variant or mutation) in ccfDNA did not discriminate between pancreatic tumor patients (i.e., cases) and controls in the individual replicates (Fig. 1A). The gene discussed is KRAS; the disease is pancreatic neoplasm.